Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
Cancer Letters|April 26, 2026
Canagliflozin Is a Novel Androgen Receptor Pathway Inhibitor for Castrate-Sensitive and Castrate-Resistant Prostate CancerAmr Ali, Fiorella Di Pastena, Olga-Demetra Biziotis, et al.Immunology Letters|September 21, 2024
Reassuring humoral and cellular immune responses to SARS-CoV-2 vaccination in participants with systemic sclerosisJenna M Benoit, Jessica A Breznik, Angela Huynh, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2022
Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 VaccinationJessica A Breznik, Angela Huynh, Ali Zhang, et al.Journal of the American Medical Directors Association|March 31, 2023
Protection from Omicron Infection in Residents of Nursing and Retirement Homes in Ontario, CanadaJessica A Breznik, Ahmad Rahim, Tara Kajaks, et al.Communications Biology|September 8, 2023
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapyAmr Ali, Bassem Mekhaeil, Olga-Demetra Biziotis, et al.Vaccine|January 1, 2026
Humoral and cellular immunogenicity of sequential heterogeneous bivalent SARS-CoV-2 vaccinations in long-term care and retirement home residentsJessica A Breznik, Jann C Ang, Hina Bhakta, et al.Molecular Therapy Oncolytics|May 6, 2020
A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell ToxicityJoanne A Hammill, Jacek M Kwiecien, Anna Dvorkin-Gheva, et al.Plos One|July 19, 2016
Correction: Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer RecurrenceAbhirami A Ananth, Lee-Hwa Tai, Casey Lansdell, et al.Plos One|May 20, 2016
Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer RecurrenceAbhirami A Ananth, Lee-Hwa Tai, Casey Lansdell, et al.Communications Biology|November 5, 2020
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitorsSamuel T Workenhe, Andrew Nguyen, David Bakhshinyan, et al.Pageof 11